TG Therapeutics Inc

TG Therapeutics Inc Stock Forecast & Price Prediction

Live TG Therapeutics Inc Stock (TGTX) Price
$15.18

4

Ratings

  • Buy 4
  • Hold 0
  • Sell 0
Disclaimer : The analyst ratings and price forecast data are provided by Tradefeeds. The data is sourced from Wall Street analysts and other experienced experts. The figures presented are solely a forecast and not a guarantee of future price performance. The information presented is not a recommendation to buy or sell the stock.

Stock Price

$15.18

P/E Ratio

P/E Ratio not available for TGTX

Volume Traded Today

$3.7M

Dividend

Dividends not available for TGTX

52 Week High/low

35.67/6.46

TG Therapeutics Inc Market Cap

$0

🛑 Alert: These ten stocks could have higher potential than $TGTX 🛑

Before you buy TGTX you’ll want to see this list of ten stocks that have huge potential. Want to see if TGTX made the cut? Enter your email below

TGTX Summary

Based on ratings from 4 stock analysts, the TG Therapeutics Inc stock price is expected to increase by 122.33% in 12 months. This is calculated by using the average 12-month stock price forecast for TG Therapeutics Inc. The lowest target is $22.00 and the highest is $45.00. Please note analyst price targets are not guaranteed and could be missed completely.

TGTX Analyst Ratings

About 4 Wall Street analysts have assignedTGTX 4 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect TG Therapeutics Inc to buy. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on TGTX. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.

TGTX stock forecast by analyst

Analyst/Firm

Rating

Price Target

Change

Date

eric joseph
J.P. Morgan

Buy

$22.0

maintained

Feb 3, 2024
mayank mamtani
B.Riley Financial

Buy

$29.0

reiterated

Feb 2, 2024
matthew kaplan
Ladenburg Thalmann & Co.

Buy

$39.0

maintained

Jan 16, 2024
edward white
H.C. Wainwright

Buy

$45.0

reiterated

Jan 11, 2024
andrea tan
Goldman Sachs

Hold

None

reiterated

Jan 9, 2024
corinne jenkins
Goldman Sachs

Hold

None

maintained

Nov 1, 2023
alec stranahan
Bank of America Securities

Sell

$6.0

reiterated

Nov 1, 2023
prakhar agrawal
Cantor Fitzgerald

Buy

$30.0

maintained

Aug 1, 2023
roger song
Jefferies

Buy

$40.0

rated

Jun 24, 2023
joshua schimmer
Evercore ISI

Buy

$38.0

maintained

May 1, 2023
chris howerton
Jefferies

Buy

$25.0

maintained

Feb 8, 2023
peter lawson
Barclays

Buy

$15.0

maintained

Mar 5, 2019
madhu kumar
Goldman Sachs

Buy

$10.0

reiterated

Oct 12, 2018
reni benjamin
JMP Securities

Buy

$22.0

maintained

Aug 14, 2018
matthew andrews
Jefferies

Buy

$23.0

maintained

Feb 5, 2018
yatin suneja
Guggenheim

Buy

None

rated

Oct 18, 2017
andrew fein
H.C. Wainwright

Buy

$18.0

reiterated

Mar 7, 2017
jason wittes
Loop Capital Markets

Buy

$26.0

initiatedcoverage

Feb 22, 2017
joseph pantginis
H.C. Wainwright

Buy

$33.0

reiterated

Dec 7, 2016
jonathan aschoff
Roth Capital

Buy

$28.0

reiterated

Aug 9, 2016

TGTX Company Information

TGTX
TG Therapeutics Inc (TGTX)

When did it IPO

0

Staff Count

0

Country

Sector/Industry

/

CEO

Market Cap

$0

TG Therapeutics Inc(TGTX) Financial Data

In 2023, TGTX generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that TGTX's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2019

N/A

Revenue From 2020

N/A

0.00 %
From Previous Year

Revenue From 2021

N/A

0.00 %
From Previous Year

Revenue From 2022

N/A

0.00 %
From Previous Year
  • Revenue TTM $0
  • Operating Margin TTM 0.00%
  • Gross profit TTM $0
  • Return on assets TTM 0.00%
  • Return on equity TTM 0.00%
  • Profit margin %
  • Book value 0.00%
  • Market capitalisation $0
  • Revenue for 2020 N/A
  • Revenue for 2021 N/A
  • Revenue for 2022 N/A
  • EPS this year N/A
  • EPS next year N/A

TG Therapeutics Inc(TGTX) Latest News

... ...

Similar Stocks to TG Therapeutics Inc TGTX

🛑 Alert: These ten stocks could have higher potential than $TGTX 🛑

Before you buy TGTX you’ll want to see this list of ten stocks that have huge potential. Want to see if TGTX made the cut? Enter your email below

...

TGTX Frequently asked questions

The highest forecasted price for TGTX is $45.00 from edward white at H.C. Wainwright.

The lowest forecasted price for TGTX is $22.00 from reni benjamin from JMP Securities

The TGTX analyst ratings consensus are 4 buy ratings, 0 hold ratings, and 0 sell ratings.